全文获取类型
收费全文 | 691篇 |
免费 | 17篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 9篇 |
妇产科学 | 3篇 |
基础医学 | 67篇 |
口腔科学 | 5篇 |
临床医学 | 66篇 |
内科学 | 212篇 |
皮肤病学 | 1篇 |
神经病学 | 92篇 |
特种医学 | 15篇 |
外科学 | 41篇 |
综合类 | 1篇 |
预防医学 | 7篇 |
眼科学 | 5篇 |
药学 | 63篇 |
中国医学 | 29篇 |
肿瘤学 | 88篇 |
出版年
2022年 | 7篇 |
2021年 | 9篇 |
2020年 | 4篇 |
2019年 | 11篇 |
2018年 | 11篇 |
2014年 | 7篇 |
2013年 | 10篇 |
2012年 | 27篇 |
2011年 | 26篇 |
2010年 | 10篇 |
2009年 | 7篇 |
2008年 | 19篇 |
2007年 | 24篇 |
2006年 | 29篇 |
2005年 | 25篇 |
2004年 | 31篇 |
2003年 | 34篇 |
2002年 | 28篇 |
2001年 | 18篇 |
2000年 | 23篇 |
1999年 | 34篇 |
1998年 | 6篇 |
1997年 | 9篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 23篇 |
1991年 | 16篇 |
1990年 | 10篇 |
1989年 | 15篇 |
1988年 | 21篇 |
1987年 | 23篇 |
1986年 | 29篇 |
1985年 | 25篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1980年 | 10篇 |
1979年 | 12篇 |
1978年 | 4篇 |
1975年 | 3篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1970年 | 3篇 |
1969年 | 4篇 |
1968年 | 4篇 |
1967年 | 6篇 |
1966年 | 3篇 |
排序方式: 共有709条查询结果,搜索用时 0 毫秒
31.
Kainuma M Hayashi J Sakai S Imai K Mantani N Kohta K Mitsuma T Shimada Y Kashiwagi S Terasawa K 《The American journal of Chinese medicine》2002,30(2-3):355-367
The purpose of this study was to determine if the adverse effects of interferon (IFN) in hepatitis C patients could be reduced by treatment with Japanese Oriental (Kampo) medicine. Twelve patients with chronic hepatitis C were treated with a combination of IFN-beta and either Mao-to or Dai-seiryu-to (groups A and B), and 16 patients were treated with IFN-beta alone (group C). Mao-to was administered to eight patients and Dai-seiryu-to was administered to four in groups A and B, respectively. Adverse effects were evaluated by clinical and laboratory examinations. The severity of symptoms was daily self-classified into four categories (1: none, 2: very slight, 3: moderate, and 4: serious), using a questionnaire consisting of 29 items. Scores of symptom such as discomfort and fever in group A, and discomfort, general malaise, paresthesia and arthralgia in group B were significantly lower than those in group C (p < 0.05). In all patients, HCV-RNA was negative at the end of the treatment, and serum alanine aminotransferase (ALT) levels had normalized transiently in all group A and B patients with genotype 1b by 2 weeks after cessation of IFN treatment. This study indicates that Kampo medicines are useful for reducing the adverse effects accompanying IFN treatment in patients with chronic hepatitis C without reducing the antiviral effects. 相似文献
32.
Inhibitory effects of Keishi-bukuryo-gan on free radical induced lysis of rat red blood cells 总被引:1,自引:0,他引:1
Keishi-bukuryo-gan (KBG) prevents the progression of atherosclerosis in cholesterol-fed rabbits by its antioxidative effect. The present study was to test our hypothesis that ingestion of KBG would protect red blood cell (RBC) membranes from free radical induced oxidation if polyphenolic antioxidants in KBG could be absorbed and circulated in the blood. When incubated with a RBC suspension, KBG and four of five herb medicines constituting KBG provided strong protection for RBC membranes against haemolysis induced by 2,2-azo-bis (2-amidinopropane) dihydrochloride (AAPH), an azo free radical initiator. The inhibitory effect was dose dependent at concentrations of 100-1000 microg/mL. Furthermore, the ingestion of 200 mg of KBG was associated with a significant decrease in susceptibility of RBC to haemolysis in rats. 相似文献
33.
Terazawa S, Kondo N, Orii T. Significance of measurement of pre-S2 antigen for the prevention of vertical transmission of hepatitis B virus in infants born to HBsAg carrier mothers. Acta Pædiatr 1994;83:30–4. Stockholm. ISSN 0803–5253
The significance of pre-S2 antigen (pre-S2 Ag) as a marker of hepatitis B virus (HBV) infection, especially in infants born to HBsAg carrier mothers who are HBeAg-negative or HBeAg-positive, was evaluated. Pre-S2 Ag was measured by enzyme immunoassay. HBsAg carrier mothers who were HBeAg-negative and HBeAb-positive were divided into two groups: group A, mothers whose infants were not infected with HBV ( n = 10) and group B, mothers whose infants were infected with HBV ( n = 13). Absorption rates of pre-S2 Ag in group A and B were 0.09 k 0.04 and 1.36 ± 0.95, respectively. The values for pre-S2 Ag in group B were significantly higher than those in group A. Values for pre-S2 Ag among HBsAg carrier mothers who were HBeAg-positive and HBeAb-negative were also measured by reversc passive hemagglutination. In the same way, HBsAg carrier mothers who were HBeAg-positive and HBeAb-negativc were divided into two groups: group C, mothers whose infants did not become HBsAg carriers ( n = 15) and group D, mothers whose infants became HBsAg carriers (n = 11). The titers of pre-S2 Ag (reverse passive hemagglutination) in group C and D were 25.75 ± 1.68 and 210.45 ±1.69 , respectively. The values for pre-S2 Ag in group D were significantly higher than those in group C. The values for pre-S2 Ag as markers of infectivity became higher with increasing amounts of HBV-DNA. Therefore, our results show that measurement of pre-S2 Ag in HBsAg carrier mothers who are HBeAg or HBeAb-positive is useful in the detection of high-risk groups of vertical transmission of HBV. 相似文献
The significance of pre-S2 antigen (pre-S2 Ag) as a marker of hepatitis B virus (HBV) infection, especially in infants born to HBsAg carrier mothers who are HBeAg-negative or HBeAg-positive, was evaluated. Pre-S2 Ag was measured by enzyme immunoassay. HBsAg carrier mothers who were HBeAg-negative and HBeAb-positive were divided into two groups: group A, mothers whose infants were not infected with HBV ( n = 10) and group B, mothers whose infants were infected with HBV ( n = 13). Absorption rates of pre-S2 Ag in group A and B were 0.09 k 0.04 and 1.36 ± 0.95, respectively. The values for pre-S2 Ag in group B were significantly higher than those in group A. Values for pre-S2 Ag among HBsAg carrier mothers who were HBeAg-positive and HBeAb-negative were also measured by reversc passive hemagglutination. In the same way, HBsAg carrier mothers who were HBeAg-positive and HBeAb-negativc were divided into two groups: group C, mothers whose infants did not become HBsAg carriers ( n = 15) and group D, mothers whose infants became HBsAg carriers (n = 11). The titers of pre-S2 Ag (reverse passive hemagglutination) in group C and D were 2
34.
Goto H Sakakibara I Shimada Y Kasahara Y Terasawa K 《The American journal of Chinese medicine》2000,28(2):197-203
Uncariae ramulus et Uncus (URE) has a vasodilator effect. Its mechanism consists of not only endothelium-independent relaxation with Ca2+ channel blocking effect but also endothelium-dependent relaxation with nitric oxide. The active components are alkaloids and tannin contained in Uncariae ramulus et Uncus. They also show a superoxide dismutase-like effect and suppressed vasocontraction induced by xanthine and xanthine oxidase. These mechanisms may also influence vasodilatation by Uncariae ramulus et Uncus in vivo. 相似文献
35.
Borchers AT Sakai S Henderson GL Harkey MR Keen CL Stern JS Terasawa K Gershwin ME 《Journal of ethnopharmacology》2000,73(1-2):1-13
The use of alternative medicine, including consumption of herbal products and dietary supplements, has been increasing substantially both in the United States and in Western Europe. One area that is garnering increased attention is the use of Oriental Medicine including Kampo, or Japanese herbal medicine. Herein, we review representative examples of research available on the most common use of Kampo medicinals, namely to improve the immune response. We also provide an extensive background on the history of Kampo. There are more than 210 different Kampo formulae used in Japan and most uses of Kampo are to modulate the immune response, i.e. to improve immunity. We have extracted data on seven common Kampo medicinals, and the data are reviewed with respect to in vitro and in vivo activities for both humans and experimental animals; the ingredients as well as the problems with classification of these materials are presented. Research suggests that Kampo herbals are biologically active and may have therapeutic potential. While it is believed that Kampo medicines have few side effects, there is a paucity of data on their toxicity as well as a relative lack of knowledge of the bioactive constituents and potential drug interactions of these agents. 相似文献
36.
Studies in the rat and rabbit indicate that facilitatory effects of neuropeptide Y (NPY) as well as norepinephrine (NE) on LH and LHRH release are dependent on the presence of the ovarian steroid estrogen. However, we have previously found the NE and an alpha-1-adrenergic agonist are both stimulatory to pulsatile LHRH release in ovariectomized rhesus monkeys. In the present experiment the effects of NPY on LHRH release were examined in conscious monkeys using a push-pull perfusion method. Twelve gonadectomized monkeys (8 females and 4 males) were used. Perfusate samples from the stalk-median eminence (S-ME) were obtained through a push-pull cannula at 10-min intervals for 12 h, and the amount of LHRH in samples were determined with RIA. NPY dissolved in a modified Krebs-Ringer phosphate buffer solution at concentrations of 10(-8), 10(-7), 10(-6), and 10(-5) M was directly infused into the S-ME through the push cannula for 10 min at 90-min intervals. Vehicle was infused as a control. Since sex differences in LHRH response to NPY were not present, data from males and females were combined for analysis. NPY infusion into the S-ME stimulated LHRH release in a dose-dependent manner (P less than 0.001). The peak LHRH responses (mean +/- SEM) to NPY at different concentrations were: 10(-8) M = 2.1 +/- 0.4 pg/ml; 10(-7) M = 2.6 +/- 0.5 pg/ml; 10(-6) M = 6.5 +/- 1.1 pg/ml; 10(-5) M = 15.1 +/- 2.9 pg/ml, whereas to vehicle 0.37 +/- 0.17 pg/ml. All NPY doses tested were significantly effective as compared to vehicle (P less than 0.01). The LHRH response to 10(-6) M was greater (P less than 0.01) than that of 10(-8) M or 10(-7) M, and the response to 10(-5) M was greater (P less than 0.01) than that of all lower doses. The results indicate that NPY infusion into the S-ME elicits the release of LHRH in vivo in a dose-dependent manner in the monkey. The data further suggest that LHRH neurons and/or neuroterminals in the monkey are responsive to NPY stimulation in the absence of gonadal steroids. It is concluded that in addition to NE, NPY is an important regulator of pulsatile LHRH release in the nonhuman primate. 相似文献
37.
38.
39.
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer 总被引:7,自引:0,他引:7
Y Sasaki S Imaoka Y Hasegawa S Nakano O Ishikawa H Ohigashi K Taniguchi H Koyama T Iwanaga T Terasawa 《Cancer》1985,55(2):311-316
Changes in the distribution of the hepatic blood flow induced by intra-arterial infusion of angiotensin II (AT-II) were studied in human hepatic cancers using extremely short-lived radioisotope (RI) (krypton 81 m [81mKr]; half-life, 13 seconds). After the start of continuous infusion of AT-II, the radioactivity of the tumor showed about a two-fold increase, whereas that of the nontumor region decreased to about one half as much as the level before the infusion. Consequently, the mean ratio of the arterial blood flow in the tumor region to that in the nontumor region (T/N ratio) increased to 3.30 (P less than 0.001). The T/N ratio showed a peak before the peripheral blood pressure reached the maximum, and thereafter tended to decrease. Intra-arterial infusion of AT-II raised the T/N ratio more obviously than did intravenous infusion of the drug, with less rise in the peripheral blood pressure. It is believed that intra-arterial infusion chemotherapy with local use of AT-II enables better accessibility of chemotherapeutic drugs to tumors. 相似文献
40.
We have reported that, using the bolus-tracking method synchronized with an injector, the injection of contrast medium in a single phase up to 10 sec before the end of the study (referred to as "single-stage injection") or the combination of single-stage injection stopped 15 sec before the end of the study and a physiological saline solution flush (referred to as "saline solution flush") makes it possible to minimize the amount of contrast medium employed in 3D-CTA of the head and neck in a scanning time of approximately 30 sec. If the continuous variable method of contrast medium injection (referred to as "variable injection") can provide the same level of contrast enhancement as that obtained with a single-stage injector for constant-rate injection, it should be possible to eliminate cumbersome study procedures associated with the saline solution flush and to simplify the study protocol. We therefore performed a comparative study to assess the contrast enhancement effect in variable injection. The results showed that variable injection provided almost the same degree of contrast enhancement as single-stage injection + saline solution flush, while permitting the amount of contrast medium to be reduced. It was concluded that variable injection (with a variation parameter of 0.5) is an effective method of improving the contrast enhancement effect and minimizing the amount of contrast medium employed, as compared with the saline solution flush method. Furthermore, it permits the examination procedures to be simplified. 相似文献